Analysis of p53 Gene Alterations in Cancer: A Critical View
Publisher
Springer Netherlands
Reference179 articles.
1. Aas, T., Borresen, A. L., Geisler, S., Smithsorensen, B., Johnsen, H., Varhaug, J. E., Akslen, L. A., and Lonning, P. E. (1996). Specific p53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients. Nature Med 2, 811-814. 2. Aguilar, F., Harris, C. C., Sun, T., Hollstein, M., and Cerutti, P. (1994). Geographic variation of p53 mutational profile in nonmalignant human liver. Science 264, 1317-1319. 3. Aguilar, F., Hussain, S. P., and Cerutti, P. (1993). Aflatoxin-B(1) induces the transversion of G->T in codon 249 of the p53 tumor suppressor gene in human hepatocytes. Proc Natl Acad Sci USA 90, 8586-8590. 4. Ahn, J., Urist, M., and Prives, C. (2003). Questioning the role of checkpoint kinase 2 in the p53 DNA damage response. J Biol Chem 278, 20480-20489. 5. Ahrendt, S. A., Halachmi, S., Chow, J. T., Wu, L., Halachmi, N., Yang, S. C., Wehage, S., Jen, J., and Sidransky, D. (1999). Rapid p53 sequence analysis in primary lung cancer using an oligonucleotide probe array. Proc Natl Acad Sci U S A 96, 7382-7387.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|